Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Views from a continent in flux.

Moedas C, Vernos I, Kuster S, Nowotny H, Saltelli A, Mungiu-Pippidi A, Wouter Vasbinder J, Brooks DR, Cunningham P.

Nature. 2019 May;569(7757):481-484. doi: 10.1038/d41586-019-01569-w. No abstract available.

PMID:
31114095
2.

Fotis Kafatos (1940-2017).

Nowotny H.

Science. 2017 Dec 15;358(6369):1387. doi: 10.1126/science.aar6095. No abstract available.

PMID:
29242334
3.

ERC-the next 10 years.

Nowotny H.

Science. 2017 Mar 10;355(6329):997. doi: 10.1126/science.aan1143. No abstract available.

PMID:
28280155
4.

EIT's teething problems.

Nowotny H, Kolar J.

Science. 2016 Aug 12;353(6300):627. doi: 10.1126/science.aah6973. No abstract available.

5.

Policy: Social-progress panel seeks public comment.

Fleurbaey M, Bouin O, Djelic ML, Kanbur R, Laborde C, Nowotny H, Reis E, Weber E, Wieviorka M, Zhang X.

Nature. 2016 Jun 30;534(7609):616-7. doi: 10.1038/534616a. No abstract available.

PMID:
27357779
6.

The radical openness of science and innovation: Why uncertainty is inherent in the openness towards the future.

Nowotny H.

EMBO Rep. 2015 Dec;16(12):1601-4. doi: 10.15252/embr.201541546. Epub 2015 Nov 9. No abstract available.

7.

Engaging with the political imaginaries of science: Near misses and future targets.

Nowotny H.

Public Underst Sci. 2014 Jan;23(1):16-20. doi: 10.1177/0963662513476220.

PMID:
24434706
8.

Preserve the European Research Council's legacy.

Nowotny H.

Nature. 2013 Dec 12;504(7479):189. doi: 10.1038/504189a. No abstract available.

PMID:
24336250
9.

Improving ERC ethical standards.

Nowotny H, Exner P.

Science. 2013 Sep 6;341(6150):1043. doi: 10.1126/science.1244098. No abstract available.

10.

A voice for science in Europe. An interview with Helga Nowotny, President of the European Research Council. Interview by Holger Breithaupt.

Nowotny H.

EMBO Rep. 2010 Sep;11(9):655-8. doi: 10.1038/embor.2010.120. Epub 2010 Aug 20. No abstract available.

11.

What the European Research Council is looking for in applications.

Nowotny H.

Bioessays. 2010 Jul;32(7):545-7. doi: 10.1002/bies.201000034. No abstract available.

PMID:
20544737
12.

Frontier research in Europe.

Nowotny H.

Science. 2010 Jun 11;328(5984):1327. doi: 10.1126/science.1190995. No abstract available.

13.

Viscosity sensor utilizing a piezoelectric thickness shear sandwich resonator.

Thalhammer R, Braun S, Devcic-Kuhar B, Groschl M, Trampler F, Benes E, Nowotny H, Kostal P.

IEEE Trans Ultrason Ferroelectr Freq Control. 1998;45(5):1331-40. doi: 10.1109/58.726459.

PMID:
18244295
14.

Science and society. High- and low-cost realities for science and society.

Nowotny H.

Science. 2005 May 20;308(5725):1117-8. No abstract available.

PMID:
15905384
15.

The emergence of the ERC.

Almeida JS, Nowotny H.

Science. 2005 Feb 25;307(5713):1200; author reply 1200. No abstract available.

PMID:
15731424
16.

Development of a novel compact sonicator for cell disruption.

Borthwick KA, Coakley WT, McDonnell MB, Nowotny H, Benes E, Gröschl M.

J Microbiol Methods. 2005 Feb;60(2):207-16.

PMID:
15590095
17.

Decisive day for European research.

Krull W, Nowotny H.

Science. 2004 Nov 5;306(5698):941. No abstract available.

18.

European research momentum.

Nowotny H.

Science. 2004 Aug 6;305(5685):753. No abstract available.

19.

Wish fulfillment and its discontents.

Nowotny H.

EMBO Rep. 2003 Oct;4(10):917-20. No abstract available.

20.

Single half-wavelength ultrasonic particle filter: predictions of the transfer matrix multilayer resonator model and experimental filtration results.

Hawkes JJ, Coakley WT, Gröschl M, Benes E, Armstrong S, Tasker PJ, Nowotny H.

J Acoust Soc Am. 2002 Mar;111(3):1259-66.

PMID:
11931302
21.

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.

Blood. 2001 Nov 15;98(10):2935-41.

22.

Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.

Nösslinger T, Reisner R, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.

Leuk Res. 2001 Sep;25(9):741-7.

PMID:
11489467
23.

Amplification of ribosomal RNA genes in acute myeloid leukemia.

Fonatsch C, Nowotny H, Pittermann-Höcker E, Streubel B, Jäger U, Valent P, Büchner T, Lechner K.

Genes Chromosomes Cancer. 2001 Sep;32(1):11-7.

PMID:
11477656
24.

Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.

Schlegelberger B, Zwingers T, Harder L, Nowotny H, Siebert R, Vesely M, Bartels H, Sonnen R, Hopfinger G, Nader A, Ott G, Müller-Hermelink K, Feller A, Heinz R.

Blood. 1999 Nov 1;94(9):3114-20.

25.

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Pfeilstöcker M, Reisner R, Nösslinger T, Grüner H, Nowotny H, Tüchler H, Schlögl E, Pittermann E, Heinz R.

Br J Haematol. 1999 Aug;106(2):455-63.

PMID:
10460606
26.

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW.

Nat Genet. 1999 May;22(1):63-8.

PMID:
10319863
27.

Cytogenetic analysis and fluorescence in situ hybridization in a case of IgD multiple myeloma.

Weinländer G, Drach J, Raderer M, Okamoto I, Ackermann J, Stögermayer B, Fazeny B, Nowotny H, Marosi C.

Cancer Genet Cytogenet. 1998 Sep;105(2):172-6.

PMID:
9723037
28.

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.

Streubel B, Sauerland C, Heil G, Freund M, Bartels H, Lengfelder E, Wandt H, Ludwig WD, Nowotny H, Baldus M, Grothaus-Pinke B, Büchner T, Fonatsch C.

Br J Haematol. 1998 Mar;100(3):521-33.

PMID:
9504635
29.

Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Nowotny H, Karlic H, Grüner H, Hirsch J, Vesely M, Nader A, Heinz R.

Ann Hematol. 1996 May;72(5):291-301.

PMID:
8645741
30.

Variant forms of Philadelphia translocation in two patients with chronic myeloid leukemia.

Valent A, Zámecníková A, Karlic H, Nowotny H, Krizan P.

Neoplasma. 1996;43(4):239-44.

PMID:
8931748
31.

Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.

Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jäger U, Heinz R, et al.

Cancer Res. 1995 Sep 1;55(17):3854-9.

32.

Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies.

Pirc-Danoewinata H, Onderka E, Porenta G, Kundi M, Nowotny H, Schlögl E, Heinz R, Kreiner G, Marosi C.

Cancer Genet Cytogenet. 1995 Apr;80(2):129-34.

PMID:
7736430
33.

Karyotype and prognosis in non-Hodgkin lymphoma.

Pirc-Danoewinata H, Chott A, Onderka E, Drach J, Schlögl E, Jäger U, Thalhammer F, Nowotny H, Aryee D, Steger GG, et al.

Leukemia. 1994 Nov;8(11):1929-39.

PMID:
7967739
34.

Rare occurrence of Philadelphia chromosome negative (but BCR-ABL positive) CML in a central European population.

Karlic H, Schlögl EE, Nowotny H, Grüner H, Valent A, Auer H, Heinz R.

Am J Hematol. 1994 Nov;47(3):253-4. No abstract available.

PMID:
7942804
35.

Clonal evolution in a transforming 5q- syndrome.

Kandioler D, Krieger O, Nowotny H, Lutz D.

Leukemia. 1994 Apr;8(4):711-2. No abstract available.

PMID:
8152269
36.

Immunophenotype of hematologic neoplasms with a translocation t(8;21).

Haas OA, Köller U, Grois N, Nowotny H.

Recent Results Cancer Res. 1993;131:361-8. No abstract available.

PMID:
8210654
37.

Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.

Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, et al.

Cancer Genet Cytogenet. 1992 Jul 1;61(1):14-25.

PMID:
1638477
38.

Trisomy 4: a specific karyotype anomaly in primary and secondary acute myeloid leukemia.

Weber E, Nowotny H, Haas OA, Kasparu H, Grois N, Lutz D.

Leukemia. 1990 Mar;4(3):219-21. Review.

PMID:
2179639
39.

Association of GP40/CD7+ acute myeloblastic leukemia and chromosome 5 aberrations.

Lutz D, Kasparu H, Nowotny H, Weber E, Krieger O, Köller U, Tüchler H, Knapp W.

Haematol Blood Transfus. 1990;33:141-4. No abstract available.

PMID:
1691128
40.

Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16?

Grois N, Nowotny H, Tyl E, Krieger O, Kier P, Haas OA.

Cancer Genet Cytogenet. 1989 Nov;43(1):119-29.

PMID:
2790767
42.

[The cytogenetics of acute leukemia].

Nowotny H, Lambrou M, Sreter L, Lutz D.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(5):781-96. German.

PMID:
2465259
43.

Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).

Jernberg H, Nilsson K, Zech L, Lutz D, Nowotny H, Scheirer W.

Blood. 1987 Jun;69(6):1605-12.

44.

Different response rates to low-dose cytosine arabinoside in acute myeloid leukemia subtypes.

Lutz D, Krieger O, Ihle R, Fekete S, Minigo H, Nowotny H, Kasparu H, Tüchler H, Köller U.

Semin Oncol. 1987 Jun;14(2 Suppl 1):121-5. No abstract available.

PMID:
3473674
45.

Hypo- and hypertetraploidy in a case of erythroleukemia analyzed by fluorochrome banding techniques.

Lambrou M, Nowotny H, Lutz D, Schweizer D.

Cancer Genet Cytogenet. 1986 Oct;23(2):115-25.

PMID:
3463401
46.

[Clinical value of various classifications in adults with AML].

Lutz D, Krieger O, Bettelheim P, Nowotny H, Köller U, Knapp W.

Onkologie. 1986 Apr;9(2):67-71. German.

PMID:
3520423
47.

[Prognostic factors in myelodysplastic syndromes: analysis of 72 cases].

Krieger O, Bernhart M, Desser H, Nowotny H, Lutz D.

Wien Klin Wochenschr. 1985 Feb 1;97(3):131-6. German.

PMID:
3984346
48.

[Specific chromosome aberrations in 3 patients with Burkitt-like leukemia (Fab: L3)].

Nowotny H, Lutz D, Krieger O, Lambrou M, Bettelheim P.

Wien Klin Wochenschr. 1985 Feb 1;97(3):153-61. German.

PMID:
3856969
49.

[The clinical significance of the Philadelphia chromosome in acute leukaemia (author's transl)].

Lutz D, Krieger O, Nowotny H, Waldner R.

Wien Klin Wochenschr. 1980 Aug 1;92(15):544-50. Review. German.

PMID:
7001767
50.

Alteration of a human lymphoblastoid cell line, REH6 during subsequent cultivation.

Scheirer W, Nowotny H, Lutz D.

Dev Biol Stand. 1980;46:101-5.

PMID:
6928838

Supplemental Content

Loading ...
Support Center